This article aims to investigate the clinical effect of misoprostol in the treatment of postpartum hemorrhage in hypertensive syndrome during pregnancy. A total of 62 cases of postpartum hemorrhage with gestational hypertension syndrome admitted to our hospital from January 2022 to January 2023 were selected as research subjects, and all patients were divided into two groups according to the randomization method, one was the experimental group (n=31) and the other was the control group (n=31). Oxytocin was given to the control group and misoprostol was given to the experimental group, and the patients were followed up to compare the blood loss, blood pressure indexes, hemoglobin level and the incidence of adverse reactions in 2 h and 4 h postpartum between the two groups. The follow-up results after treatment showed that the blood loss, blood pressure indexes and the incidence of adverse reactions in the experimental group were lower than those in the control group at 2 h and 4 h postpartum, and the data comparison difference was statistically significant (P<0.05), and the hemoglobin level in the experimental group was higher than that in the control group, and the data comparison difference was statistically significant (P<0.05). Misoprostol has a good efficacy in the treatment of postpartum hemorrhage in pregnancy-induced hypertension syndrome. The use of misoprostol significantly reduces the amount of postpartum haemorrhage and the incidence of adverse effects, and can be used in obstetrics and gynaecology clinical practice to prevent and treat postpartum haemorrhage in pregnancy-induced hypertension syndrome.

Lingyan Zhang. Efficacy of Misoprostol in the Treatment of Postpartum Haemorrhage in Hypertensive Syndrome During Pregnancy. Academic Journal of Medicine & Health Sciences (2023) Vol. 4, Issue 8: 43-48. https://doi.org/10.25236/AJMHS.2023.040808.

[1] Zhihong Zhou. The Clinical Efficacy and Safety of Misoprostol in the Treatment of Hypertensive Syndrome Complicating Pregnancy Postpartum Bleeding [J]. Journal of Clinical Rational Drug Use, 2020, 13 (03): 93-95

[2] Jie Xiao, Wenli Wang. Observation on the Clinical Efficacy of Misoprostol in the Treatment of Pregnancy Induced Hypertension Syndrome Postpartum Bleeding [J]. Journal of Clinical Rational Drug Use, 2019, 12 (25): 83-84. DOI: 10. 15887/j. cnki. 13-1389/r. 2019. 25. 049

[3] Changhong Liu. Clinical Characteristics and Treatment Effects of Obstetric Pregnancy Induced Hypertension Syndrome [J]. Journal of Practical Cardio Cerebro Pulmonary Vascular Disease, 2021, 29 (S1): 78-79

[4] Shuilian Yang, Junrong Yang. The Effect of Nifedipine+Labetalol+Magnesium Sulfate on Hemorheology, Inflammatory Factors, and Vascular Endothelial Function in Patients with Pregnancy induced Hypertension Syndrome [J]. Clinical Medical Research and Practice, 2021, 6 (15): 66-68+71

[5] Jiao’e Yang. Analysis on the Effect of Labetalol Combined with Magnesium Sulfate in the Treatment of Hypertensive Syndrome Complicating Pregnancy and the Outcome of Improving Pregnancy [J]. World Journal of Complex Medicine, 2021, 7 (02): 160-162

[6] Li Wang, Yanjie Gao. Clinical Efficacy of Magnesium Sulfate Combined with Nifedipine and Phentolamine in the Treatment of Pregnancy Induced Hypertension Syndrome [J]. Journal of Clinical Rational Drug Use, 2020, 13 (33): 91-92

[7] Yanbing Fu. Clinical Study on the Treatment of Pregnancy Induced Hypertension Syndrome with Magnesium Sulfate and Nifedipine [J]. Practical Gynecological Endocrine Online magazine, 2020, 7 (25): 16+18

[8] Qin Luo. Analysis of the Efficacy of Nifedipine Sustained-release Tablets, Magnesium Sulfate Injection and Phentolamine in the Treatment of Pregnancy Induced Hypertension Syndrome [J]. Practical Gynecological Endocrine Online Magazine, 2020, 7 (22): 31+37

[9] Nan Li. Clinical Efficacy of Magnesium Sulfate Combined with Nifedipine in the Treatment of Hypertensive Syndrome Complicating Pregnancy [J]. China Modern Doctor, 2020, 58 (13): 68-71

[10] Leilei Cui, Minxia Kang. Analysis of the Efficacy of Magnesium Sulfate Combined with Nifedipine in the Treatment of Pregnancy Induced Hypertension Syndrome [J]. Drug Evaluation, 2020, 17 (05): 30-31+42

[11] Lijun Qu. Effect of Modified Yiqi Yangyin Decoction Combined with Labetalol on Blood Pressure Control and Pregnancy Outcome in Patients with Pregnancy Induced Hypertension Syndrome [J]. Chinese Folk Therapy, 2019, 27 (07): 70-71